Gene · 1105
Papers1,932
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,932
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer. | J Exp Clin Cancer Res | 2025 | 40229848 | PubTator, text mining | PubMed |
| Environmental toxicant 2,3,7,8-tetrachlorodibenzo-p-dioxin induces non-obstructive azoospermia: New insights from network toxicology, integrated machine learning, and biomolecular modeling. | Ecotoxicol Environ Saf | 2025 | 40215689 | PubTator, text mining | PubMed |
| Semisynthesis of Isomerized Histone H4 Reveals Robustness and Vulnerability of Chromatin toward Molecular Aging. | J Am Chem Soc | 2025 | 39894946 | PubTator, text mining | PubMed |
| Beyond the mono-nucleosome. | Biochem Soc Trans | 2025 | 39887339 | PubTator, text mining | PubMed |
| UCS: A Unified Approach to Cell Segmentation for Subcellular Spatial Transcriptomics. | Small Methods | 2025 | 39763408 | PubTator, text mining | PubMed |
| Hypoxia-selective prodrug restrains tumor cells through triggering mitophagy and inducing apoptosis. | Eur J Med Chem | 2025 | 39657461 | PubTator, text mining | PubMed |
| A hypothetical model: Chromatin remodelers couple with acetyltransferases to trigger the elongation of RNA polymerase II (pol II). | Front Epigenet Epigenom | 2024 | 41425263 | PubTator, text mining | PubMed |
| Optimizing dual energy X-ray image enhancement using a novel hybrid fusion method. | J Xray Sci Technol | 2024 | 39729441 | PubTator, text mining | PubMed |
| Discovery of CHD1 Antagonists for PTEN-Deficient Prostate Cancer. | J Med Chem | 2024 | 39508435 | PubTator, text mining | PubMed |
| RETRACTION: MATN1-AS1 promotes glioma progression by functioning as ceRNA of miR-200b/c/429 to regulate CHD1 expression. | Cell Prolif | 2024 | 39428107 | PubTator, text mining | PubMed |
| Finish the unfinished: Chd1 resolving hexasome-nucleosome complex with FACT. | Mol Cell | 2024 | 39303676 | PubTator, text mining | PubMed |
| Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression. | NPJ Precis Oncol | 2024 | 39294262 | PubTator, text mining | PubMed |
| How does CHD4 slide nucleosomes? | Biochem Soc Trans | 2024 | 39221830 | PubTator, text mining | PubMed |
| Prognosis and metabolism with a Golgi apparatus-related genes-based formula in breast cancer. | Medicine (Baltimore) | 2024 | 39151519 | PubTator, text mining | PubMed |
| Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing. | Am J Clin Nutr | 2024 | 39025327 | PubTator, text mining | PubMed |
| Dysregulated Urinary Extracellular Vesicle Small RNAs in Diabetic Nephropathy: Implications for Diagnosis and Therapy. | J Endocr Soc | 2024 | 38966710 | PubTator, text mining | PubMed |
| SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1-Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC. | Adv Sci (Weinh) | 2024 | 38864559 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor. | Asian Pac J Cancer Prev | 2024 | 38809626 | PubTator, text mining | PubMed |
| Histone H3 posttranslational modified enzymes defined neutrophil plasticity and their vulnerability to IL-10 in the course of the inflammation. | J Inflamm (Lond) | 2024 | 38745328 | PubTator, text mining | PubMed |
| Polymerase Chain Reaction (PCR) is a Useful and Low-Cost Tool for Molecular Sexing Psittaciformes under Human Care: An Example of a Collaborative Approach in Mexico. | J Appl Anim Welf Sci | 2024 | 38725189 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1105/papers?page=4